I
IPCA Laboratories
IPCALAB Share Price
Healthcare1,451.00
as on 13 Apr 2026 at 15:56
Market Cap
₹36,812 Cr
PE Ratio
39.30
ROCE
12.97%
IPCALAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
36,812
PE Ratio
39.30
PB Ratio
4.97
Dividend Yield
0.27%
ROE
9.39%
ROCE
12.97%
Book Value (₹)
292.74
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% |
| Domestic Institutional Investors (DII) | 36.06% | 36.20% | 36.77% | 37.32% | 37.45% |
| Foreign Institutional Investors (FII) | 10.76% | 10.67% | 10.43% | 10.63% | 10.63% |
| Public Investors | 6.81% | 6.82% | 6.55% | 5.88% | 5.79% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
IPCALAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
524494
NSE Scrip Name
IPCALAB
ISIN
INE571A01038



